Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol;

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s